Navigation Links
Endologix Reports 30% Third Quarter 2010 Revenue Growth
Date:10/27/2010

nce call to discuss these topics today beginning at 5:30 p.m. Eastern time (2:30 p.m. Pacific time).  To participate via telephone please call (877) 407-0789 from the U.S. or (201) 689-8562 from outside the U.S.  A telephone replay will be available for seven days following the completion of the call by dialing (877) 870-5176 from the U.S. or (858) 384-5517 from outside the U.S., and entering pin number 358458.  The conference call will be broadcast live over the Internet at www.endologix.com and will be available for 30 days.

About EndologixEndologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders.  The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement.  Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture.  The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

Additional Information About the Proposed Transaction and Where to Find ItThis press release may be deemed soliciting material relating to the proposed transaction between Endologix, Inc. and Nellix, Inc.  In connection with the proposed transaction, Endologix, Inc. will file a proxy statement and other relevant documents with the Securities and Exchange Commission. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT AND THESE OTHER DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ENDOLOGIX, INC. AND THE PROPOSED TRANSACTION.  Investors and security hol
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014   InnFocus, Inc ., reported on results of ... for up to 3 years with the InnFocus ... Chicago . The Summit ... meeting of the American Academy of Ophthalmology . The ... glaucoma patients in 6 countries by early 2015. ...
(Date:10/17/2014)... 2014  China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... received approval from the China Food and Drug ... prothrombin complex concentrate ("PCC") at its Shandong Taibang ... factor production facility for Good Manufacturing Practices ("GMP") ...
(Date:10/17/2014)... --  DaVita HealthCare Partners Inc. (NYSE: ... and most innovative health care communities, recently held ... award-winning, leadership development and cultural orientation program for ... the globe were in attendance for the event. ... two-day one-of-a-kind experience for new and recently hired ...
Breaking Medicine Technology:InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3
... The American Association for Homecare supports tough anti-fraud ... and Commerce subcommittee hearing on this issue this week ... taxpayer dollars. The American Association for Homecare represents providers ... We have zero tolerance for fraud and ...
... Sept. 22 NewBridge Pharmaceuticals announced that it has ... AB (STO: ORX) that grants NewBridge rights to seek ... cancer pain, in the Middle East and Africa and, ... product in these territories.  The agreement covers 64 countries ...
Cached Medicine Technology:Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 2Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 3Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 4Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 5Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 6Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths 7NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 2NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 3NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 4
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... famous for talking to animals, then here,s a story that ... published online in The FASEB Journal ( http://www.fasebj.org ... subcutaneous adipose (fat) tissue with muscle cells from rat hearts. ... cells altogether, but they actually beat. "Recovery of regenerative ...
... Grafton, Mass., February 28, 2011 Researchers at the Cummings ... an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially ... leading cause of kidney failure in children. HUS is ... produce Shiga toxins and are responsible for about 100,000 annual ...
... lll. A farmer in Niger learns how to protect ... rural Haitian village learns how to avoid exposure to cholera. ... oil from shea seeds to make shea butter she can ... from a new approach to sustainable development education that reaches ...
... WASHINGTON, February 28, 2011) Results from a study ... American Society of Hematology reveal a close relationship between ... arteries carrying blood from the heart to the lungsand ... (known as myeloid abnormalities). The study, which was ...
... in breast cancer incidence rates among non-Hispanic white women ... use of postmenopausal hormone therapy did not continue through ... Cancer Society and the National Cancer Institute. While there ... may indicate that the decrease in breast cancers thought ...
... (HealthDay News) -- A new study finds that heart attack ... other heart attack patients to receive priority care at emergency ... patients admitted to 96 hospitals in the province of Ontario ... had a history of depression recorded in their medical charts. ...
Cached Medicine News:Health News:Human stem cells from fat tissue fuse with rat heart cells and beat 2Health News:Tufts receives patent for antibody treatment against hemolytic uremic syndrome 2Health News:Team delivers development aid via cell phone animations 2Health News:Team delivers development aid via cell phone animations 3Health News:Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities 2Health News:Study finds breast cancer incidence rates no longer declining in US women 2Health News:Heart Patients With Depression Often Find ER Delays 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: